| Systematic identification of genomic markers of drug sensitivity in cancer cells MJ Garnett, EJ Edelman, SJ Heidorn, CD Greenman, A Dastur, KW Lau, ... Nature 483 (7391), 570-575, 2012 | 2606 | 2012 |
| Targeting Bcr–Abl by combining allosteric with ATP-binding-site inhibitors J Zhang, FJ Adrián, W Jahnke, SW Cowan-Jacob, AG Li, RE Iacob, T Sim, ... Nature 463 (7280), 501-506, 2010 | 694 | 2010 |
| Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders H Jiang, H He, Y Chen, W Huang, J Cheng, J Ye, A Wang, J Tao, C Wang, ... Journal of Experimental Medicine 214 (11), 3219-3238, 2017 | 612 | 2017 |
| Mutations in the DDR2 Kinase Gene Identify a Novel Therapeutic Target in Squamous Cell Lung Cancer PS Hammerman, ML Sos, AH Ramos, C Xu, A Dutt, W Zhou, LE Brace, ... Cancer discovery 1 (1), 78-89, 2011 | 589 | 2011 |
| Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity H He, H Jiang, Y Chen, J Ye, A Wang, C Wang, Q Liu, G Liang, X Deng, ... Nature communications 9 (1), 2550, 2018 | 565 | 2018 |
| Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2 X Deng, N Dzamko, A Prescott, P Davies, Q Liu, Q Yang, JD Lee, ... Nature chemical biology 7 (4), 203-205, 2011 | 475 | 2011 |
| Tranilast directly targets NLRP 3 to treat inflammasome‐driven diseases Y Huang, H Jiang, Y Chen, X Wang, Y Yang, J Tao, X Deng, G Liang, ... EMBO molecular medicine 10 (4), e8689, 2018 | 413 | 2018 |
| Pharmacological targeting of kinases MST1 and MST2 augments tissue repair and regeneration F Fan, Z He, LL Kong, Q Chen, Q Yuan, S Zhang, J Ye, H Liu, X Sun, ... Science translational medicine 8 (352), 352ra108-352ra108, 2016 | 341 | 2016 |
| Low-dose metformin targets the lysosomal AMPK pathway through PEN2 T Ma, X Tian, B Zhang, M Li, Y Wang, C Yang, J Wu, X Wei, Q Qu, Y Yu, ... Nature 603 (7899), 159-165, 2022 | 320 | 2022 |
| Pharmacological inhibition of BMK1 suppresses tumor growth through promyelocytic leukemia protein Q Yang, X Deng, B Lu, M Cameron, C Fearns, MP Patricelli, JR Yates, ... Cancer cell 18 (3), 258-267, 2010 | 235 | 2010 |
| Enantioselective synthesis of vinylcyclopropanes and vinylepoxides mediated by camphor-derived sulfur ylides: rationale of enantioselectivity, scope, and limitation XM Deng, P Cai, S Ye, XL Sun, WW Liao, K Li, Y Tang, YD Wu, LX Dai Journal of the American Chemical Society 128 (30), 9730-9740, 2006 | 203 | 2006 |
| Integration of Hippo signalling and the unfolded protein response to restrain liver overgrowth and tumorigenesis H Wu, L Wei, F Fan, S Ji, S Zhang, J Geng, L Hong, X Fan, Q Chen, J Tian, ... Nature communications 6 (1), 6239, 2015 | 173 | 2015 |
| GSK2578215A; a potent and highly selective 2-arylmethyloxy-5-substitutent-N-arylbenzamide LRRK2 kinase inhibitor AD Reith, P Bamborough, K Jandu, D Andreotti, L Mensah, P Dossang, ... Bioorganic & medicinal chemistry letters 22 (17), 5625-5629, 2012 | 172 | 2012 |
| Glycogen accumulation and phase separation drives liver tumor initiation Q Liu, J Li, W Zhang, C Xiao, S Zhang, C Nian, J Li, D Su, L Chen, Q Zhao, ... Cell 184 (22), 5559-5576. e19, 2021 | 165 | 2021 |
| Hippo signaling suppresses cell ploidy and tumorigenesis through Skp2 S Zhang, Q Chen, Q Liu, Y Li, X Sun, L Hong, S Ji, C Liu, J Geng, ... Cancer cell 31 (5), 669-684. e7, 2017 | 142 | 2017 |
| Brain penetrant LRRK2 inhibitor HG Choi, J Zhang, X Deng, JM Hatcher, MP Patricelli, Z Zhao, DR Alessi, ... ACS medicinal chemistry letters 3 (8), 658-662, 2012 | 137 | 2012 |
| The Ets transcription factor GABP is a component of the hippo pathway essential for growth and antioxidant defense H Wu, Y Xiao, S Zhang, S Ji, L Wei, F Fan, J Geng, J Tian, X Sun, F Qin, ... Cell reports 3 (5), 1663-1677, 2013 | 135 | 2013 |
| Rapid 3D printing of functional nanoparticle-enhanced conduits for effective nerve repair J Tao, J Zhang, T Du, X Xu, X Deng, S Chen, J Liu, Y Chen, X Liu, ... Acta biomaterialia 90, 49-59, 2019 | 134 | 2019 |
| High-throughput kinase profiling: a more efficient approach toward the discovery of new kinase inhibitors CV Miduturu, X Deng, N Kwiatkowski, W Yang, L Brault, ... Chemistry & biology 18 (7), 868-879, 2011 | 134 | 2011 |
| TLR4 signalling via Piezo1 engages and enhances the macrophage mediated host response during bacterial infection J Geng, Y Shi, J Zhang, B Yang, P Wang, W Yuan, H Zhao, J Li, F Qin, ... Nature communications 12 (1), 3519, 2021 | 133 | 2021 |
